1. Home
  2. BBGI vs SNGX Comparison

BBGI vs SNGX Comparison

Compare BBGI & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beasley Broadcast Group Inc.

BBGI

Beasley Broadcast Group Inc.

SELL

Current Price

$21.51

Market Cap

10.5M

ML Signal

SELL

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$1.25

Market Cap

11.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBGI
SNGX
Founded
1961
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
11.2M
IPO Year
1999
2006

Fundamental Metrics

Financial Performance
Metric
BBGI
SNGX
Price
$21.51
$1.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
2.2M
174.9K
Earning Date
04-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.03
EPS
N/A
N/A
Revenue
$232,179,463.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
69.89
N/A
52 Week Low
$3.14
$1.00
52 Week High
$26.37
$6.23

Technical Indicators

Market Signals
Indicator
BBGI
SNGX
Relative Strength Index (RSI) 86.23 55.06
Support Level $3.93 $1.19
Resistance Level $26.37 $1.22
Average True Range (ATR) 2.95 0.05
MACD 1.60 0.00
Stochastic Oscillator 89.20 79.31

Price Performance

Historical Comparison
BBGI
SNGX

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: